Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives

Cardiovascular diseases (CVDs) remain the major public health concern worldwide. Over the last two decades, a considerable amount of literature has been published on gut microbiota (GMB) composition and its metabolites, involved in the pathophysiology of CVDs, including arterial hypertension, atrial...

Descripción completa

Detalles Bibliográficos
Autores principales: Drapkina, Oxana M., Yafarova, Adel A., Kaburova, Anastasia N., Kiselev, Anton R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406184/
https://www.ncbi.nlm.nih.gov/pubmed/36009566
http://dx.doi.org/10.3390/biomedicines10082019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406184/
https://www.ncbi.nlm.nih.gov/pubmed/36009566
http://dx.doi.org/10.3390/biomedicines10082019

Ejemplares similares